Advisory Board members

The Advisory Board offers periodic guidance on the structure and composition of the Editorial Board, provides perspective on the scientific landscape in which the Molecule Pages database operates, and suggests possible strategies and priorities for the development of the project. Decisions concerning all aspects of the Molecule Pages database rest entirely with NPG and UCSD.

Tony Hunter
Tony Hunter, Ph.D., is a Professor in the Molecular and Cell Biology Laboratory at the Salk Institute. His studies include how cells regulate their growth and division, and how mutations in genes that regulate growth lead to cancer. His lab has made significant contributions in the area of signal transduction.

Robin Irvine
Robin Irvine, Ph.D., FRS, is a Professor in the Department of Pharmacology at the University of Cambridge whose principal interest is the physiology of inositides (inositol lipids and phosphates). Most of his lab's work focuses on the kinases that phosphorylate inositides and the functions of their substrates and products, including exploration of possible effectors.

Michael Berridge
Sir Michael Berridge, Ph.D., FRS, is an Emeritus Fellow at the Babraham Institute and Honorary Professor of Cell Signaling at the University of Cambridge. In September 2005 Professor Berridge was awarded the prestigious Shaw Prize for his pioneering work in the field of cell signaling. He discovered the key role that inositol trisphosphate and calcium plays in regulating cellular activity and orchestrating the complexities of cellular communication. He has served as a distinguished ambassador for all who work in the calcium signaling field.

Patrick Casey
Patrick Casey, Ph.D., is a Professor of Pharmacology and Cancer Biology and the Director of the Center for Chemical Biology at Duke University Medical Center. Research in his laboratory focuses on signaling mediated through guanine nucleotide-binding regulatory proteins (G proteins). He is currently based in Singapore where he is the Senior Vice Dean of Research and at the new Duke-NUS Graduate Medical School, a collaboration between Duke University and the National University of Singapore.

Vishva Dixit
Vishva Dixit, M.D., is the Vice President of Research at Genentech. His lab’s focus is on the characterization of components of the apoptotic or death pathway and the biochemistry of ubiquitination.

Ravi Iyengar
Ravi Iyengar, Ph.D., is the Professor & Chair of the Pharmacology And Systems Therapeutics department at Mount Sinai School of Medicine. His lab focuses on the study of cellular signaling systems with a special emphasis on signaling through heterotrimeric G proteins and is particularly interested in understanding the relationships between organization of signaling networks and cellular decision making processes.

Editorial Board Members

We are greatly appreciative of our outstanding team of editorial board members. Our editorial board members provide their expertise and insight in identifying authors for new Molecule Pages within their research field, suggest potential reviewers for Molecule Pages and provide guidance on the individual Molecule Pages assigned to them.

Joseph P. Albanesi	UT Southwestern Medical Center
Dafna Bar-Sagi	Stony Brook University
Catherine Berlot	Weis Center for Research
Donald P. Bottaro	National Cancer Institute
Michael J. Brownstein	Venter Institute
Robert D. Burgoyne	University of Liverpool
Lena Claesson-Welsh	Uppsala University
Shamshad Cockcroft	University College London
Paul A. Dawson	Wake Forest University
Nicholas G. Davis	Wayne State University
Michael Dean	National Cancer Institute-FCRDC
Annette Dolphin	University College London
Haian Fu	Emory University School of Medicine
James C. Garrison	University of Virginia
Michael P. Graziano	Schering Plough Research Institute
Donald E. Gullberg	University of Bergen
T. Kendall Harden	University of North Carolina, Chapel Hill
Ronald T. Hay	University of Dundee
Nobutaka Hirokawa	University of Tokyo
Miles Houslay	University of Glasgow
Richard A. Kahn	Emory University School of Medicine
Jack D. Keene	Duke University Medical Center
Stephen M. Keyse	Cancer Research UK
John M. Kyriakis	Tufts University School of Medicine
Maurine E. Linder	Washington University School of Medicine
Jennifer Lippincott-Schwartz	National Institutes of Health
Fumio Matsumura	Rutgers University
Toru Miki	National Cancer Institute
Randall T. Moon	University of Washington
Philip M. Murphy	National Institutes of Health
Benjamin G. Neel	Beth Israel Deaconess Medical Center
Luke O'Neill	University of Dublin, Trinity College
Edward Plow	Lerner Research Institute
Richard T. Premont	Duke University Medical Center
Howard Schulman	Pharmaceutical Product Development, Inc.
John D. Scott	Vollum Institute, Oregon Health & Science University
Sarah Spiegel	Virginia Commonwealth University
Andreas Strasser	Walter and Eliza Hall Institute of Medical Research
Jeremy W. Thorner	University of California, Berkeley
Nicholas Tonks	Cold Spring Harbor Laboratory
Bart Vanhaesebroeck	University College London
Li-Na Wei	University of Minnesota Medical School
Michael A. White	UT Southwestern Medical Center
Thomas M. Wilkie	UT Southwestern Medical Center